申请人:Merck & Co., Inc.
公开号:US05502053A1
公开(公告)日:1996-03-26
Compounds of formula ##STR1## are HIV protease inhibitors, and are synthesized via a novel route. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
式子为##STR1##的化合物是HIV蛋白酶抑制剂,通过一种新颖的途径合成。这些化合物可作为化合物、药学上可接受的盐、制药组分使用,无论是否与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用,都可用于预防或治疗HIV感染和治疗艾滋病。还描述了治疗艾滋病的方法以及预防或治疗HIV感染的方法。